Adeno-Associated Virus Gene Therapy: Is There a Risk of Insertional Mutagenesis?
Paul Batty · 2026
Read Adeno-Associated Virus Gene Therapy: Is There a Risk of Insertional Mutagenesis? by Paul Batty (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13478430.txt.
Description
Paul Batty reviewed in 2026 whether adeno-associated virus gene therapy risks insertional mutagenesis, where vector DNA lands in the genome and disrupts genes. Approved for several rare single-gene disorders, these vectors mostly persist as episomes outside chromosomes, with rare integration.
Wild-type virus integration appears in a small number of liver cancer cases, at most a minor risk factor, and structural differences limit translation to therapeutic vectors. Early mouse studies showed insertional mutagenesis, but findings were inconsistent and context-dependent, tied to high doses or neonatal treatment. No such reports exist in large animals or human biopsies. Long-term safety monitoring remains warranted.
Catalog record
| CREATOR | Paul Batty |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 24 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |